Cargando…

Factor Structure of the Clinician-Rated Dimensions of Psychosis Symptom Severity in Patients with Schizophrenia

Detalles Bibliográficos
Autores principales:	Park, Seon-Cheol, Lee, Kang Uk, Choi, Joonho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neuropsychiatric Association 2016
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823205/ https://www.ncbi.nlm.nih.gov/pubmed/27081390 http://dx.doi.org/10.4306/pi.2016.13.2.253

Ejemplares similares

Using the Young Mania Rating Scale for Identifying Manic Symptoms in Patients with Schizophrenia
por: Park, Seon-Cheol, et al.
Publicado: (2016)

M118. FACTOR STRUCTURE OF THE CLINICIAN-RATED DIMENSION OF PSYCHOSIS SYMPTOM SEVERITY IN PATIENTS WITH EARLY PSYCHOSIS
por: Lee, Kyuyoung, et al.
Publicado: (2020)

M95. DSM-5 CLINICIAN-RATED DIMENSIONS OF PSYCHOSIS SYMPTOM SEVERITY: PSYCHOMETRIC PROPERTIES
por: Liemburg, Edith, et al.
Publicado: (2020)

S110. THE CLINICAL IMPLICATION OF CLINICIAN-RATED DIMENSIONS OF PSYCHOSIS SYMPTOM SEVERITY (CRDPSS) FOR DIAGNOSIS BY DSM-5
por: Nam, Beomwoo, et al.
Publicado: (2018)

Affective dimension of early psychosis and suicidality
por: Durmaz, Onur
Publicado: (2018)

F95. ASSESSING MANIC SYMPTOMS IN PATIENTS WITH SCHIZOPHRENIA USING THE YOUNG MANIA RATING SCALE
por: Kim, Tae Yong, et al.
Publicado: (2018)

Toluene associated schizophrenia-like psychosis
por: Rao, Naren P., et al.
Publicado: (2009)

S128. CORRELATION OF DURATION OF UNTREATED PSYCHOSIS WITH TREATMENT RESPONSE ON THE SYMPTOM DIMENSIONS OF SCHIZOPHRENIA
por: Elias, Beatriz Yukie, et al.
Publicado: (2018)

Symptom Dimensions of the Psychotic Symptom Rating Scales in Psychosis: A Multisite Study
por: Woodward, Todd S., et al.
Publicado: (2014)

Panic psychosis: paroxysmal panic anxiety concomitant with auditory hallucinations in schizophrenia
por: Gabínio, Thalita, et al.
Publicado: (2017)

A new nosology of psychosis and the pharmacological basis of affective and negative symptom dimensions in schizophrenia
por: Vakalopoulos, Costa
Publicado: (2010)

Psychosis and Schizophrenia-Spectrum Personality Disorders Require Early Detection on Different Symptom Dimensions
por: Schultze-Lutter, Frauke, et al.
Publicado: (2019)

Negative dimension stability across clinical stages and sociodemographic characteristics in schizophrenia
por: Koga, Gabriela, et al.
Publicado: (2022)

Calloso-frontal tuberculoma presenting with symptoms of psychosis and catatonia
por: Das, Sourav, et al.
Publicado: (2015)

A Novel Bio-Psychosocial-Behavioral Treatment Model in Schizophrenia
por: Kim, Yong-Ku, et al.
Publicado: (2017)

Exploration of symptom dimensions and duration of untreated psychosis within a staging model of schizophrenia spectrum disorders
por: Berendsen, Steven, et al.
Publicado: (2020)

Psychometric Properties of the Korean Version of the Clinical Language Disorder Rating Scale (CLANG)
por: Park, Seon-Cheol, et al.
Publicado: (2016)

Besides Symptoms: Unheard Narratives in Research on Schizophrenia
por: Mehrotra, Seema, et al.
Publicado: (2013)

S91. CLINICAL CHARACTERISTICS OF FORMAL THOUGHT DISORDER IN SCHIZOPHRENIA
por: Choi, Joonho, et al.
Publicado: (2018)

Network Analysis of Language Disorganization in Patients with Schizophrenia
por: Park, Seon-Cheol, et al.
Publicado: (2020)

Cervical cancer screening and psychosis: a longitudinal retrospective study comparing women with schizophrenia spectrum disorders and the general population
por: Vázquez-Bourgon, Javier, et al.
Publicado: (2022)

Severe chronic psychosis after allogeneic SCT from a schizophrenic sibling
por: Sommer, I E, et al.
Publicado: (2015)

PM400. Differences in assessing insight into psychosis between clinicians and patients with schizophrenia
por: Kwak, Sook Young, et al.
Publicado: (2016)

Clinicians and Information Technology
por: Wood, J. D. D., et al.
Publicado: (1991)

Friends and Symptom Dimensions in Patients with Psychosis: A Pooled Analysis
por: Giacco, Domenico, et al.
Publicado: (2012)

Tramadol withdrawal psychosis
por: Sidana, Ajeet, et al.
Publicado: (2019)

RE-EMERGENCE OF POSITIVE SYMPTOMS OF SCHIZOPHRENIA DURING THE COURSE OF TREATMENT WITH RISPERIDONE
por: Sivaprakash, B., et al.
Publicado: (1999)

The Flynn Effect : An Alert to Clinicians
por: Sarkar, Jaydip
Publicado: (2004)

Cyclical vomiting and clinician's dilemma
por: Chatterjee, Seshadri Sekhar, et al.
Publicado: (2021)

Clinician-to-clinician electronic consultation in cardiology is also a digital health technology for cardiovascular care
por: González-Juanatey, José R, et al.
Publicado: (2023)

Statin-Induced Immune-Mediated Necrotizing Myopathy Does Not Always Present With Immediate or Severe Symptoms
por: Kang, Minsung, et al.
Publicado: (2022)

Olanzapine has poorer efficacy than risperidone for the treatment of the negative symptoms of schizophrenia
por: Vadlamani, Laxmi Naresh, et al.
Publicado: (2017)

Zika virus infection and psychosis
por: Joob, Beuy, et al.
Publicado: (2018)

Psychosis: glia, immunity, and melatonin
por: Anderson, George
Publicado: (2017)

Cerebral white matter structure is associated with DSM-5 schizophrenia symptom dimensions
por: Viher, Petra V., et al.
Publicado: (2016)

New-onset psychosis: A case report of brief psychosis related to COVID-19 infection
por: Alba, Leila, et al.
Publicado: (2021)

Intralymphatic Immunotherapy Alleviates Allergic Symptoms During Allergen Exposure in Daily Life
por: Lee, Sang Pyo, et al.
Publicado: (2018)

Symptom dimensions are associated with reward processing in unmedicated persons at risk for psychosis
por: Wotruba, Diana, et al.
Publicado: (2014)

Associations between symptom and neurocognitive dimensions in clinical high risk for psychosis
por: Aase, Ingvild, et al.
Publicado: (2022)

Saccadic eye movements in different dimensions of schizophrenia and in clinical high-risk state for psychosis
por: Obyedkov, Ilya, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nh9fgpceadvkugttrq5r24760v